FDA grants accelerated approval to pembrolizumab for advanced HNSCCAugust 9, 2016Head & Neck/Thyroid Cancers
Testosterone might counteract chemotherapy heart damageAugust 2, 2016Head & Neck/Thyroid CancersGynecologic Cancer
FDA grants priority review to nivolumab for head and neck cancerJuly 20, 2016Head & Neck/Thyroid CancersGenitourinary Cancer
SU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerHead & Neck/Thyroid CancersMelanomaImmuno-oncologyRenal Cell Carcinoma
Pembrolizumab paired with immunostimulator is safe and tolerableJune 15, 2016Genitourinary CancerHead & Neck/Thyroid CancersLung CancerImmuno-oncology
MyPathway: Targeted therapies show promise in nonindicated tumorsJune 8, 2016GastroenterologyLung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersMelanomaRare Diseases
Resection of recurrence shows survival benefit for adrenocortical carcinomaMay 25, 2016Head & Neck/Thyroid Cancers
Sentinel node biopsies may be useful in head and neck squamous cell carcinomaMay 23, 2016MelanomaHead & Neck/Thyroid Cancers
Surgery has edge over surveillance for micropapillary thyroid cancerApril 23, 2016Head & Neck/Thyroid Cancers
VIDEO: Proposed revision of medullary thyroid cancer staging improves risk-stratification analysisApril 12, 2016Head & Neck/Thyroid Cancers
VIDEO: More routine use of unilateral thyroidectomy advocated for papillary thyroid microcarcinomaApril 8, 2016Head & Neck/Thyroid Cancers
Thyroid surgery access and acceptance varies along racial linesMarch 17, 2016Head & Neck/Thyroid Cancers
Insurance status affects treatment, outcomes for patients with head and neck cancerMarch 9, 2016Head & Neck/Thyroid Cancers
